GSE,Sample_title,Sample_geo_accession,Sample_status,Sample_submission_date,Sample_last_update_date,Sample_type,Sample_channel_count,Sample_source_name_ch1,Sample_organism_ch1,Sample_taxid_ch1,Sample_treatment_protocol_ch1,Sample_growth_protocol_ch1,Sample_molecule_ch1,Sample_extract_protocol_ch1,Sample_data_processing,Sample_platform_id,Sample_contact_name,Sample_contact_institute,Sample_contact_address,Sample_contact_city,Sample_contact_state,Sample_contact_zip/postal_code,Sample_contact_country,Sample_instrument_model,Sample_library_selection,Sample_library_source,Sample_library_strategy,Sample_series_id,Sample_data_row_count,file,file_url,sample_name,file_size,type,tissue,cell line,passages,BioSample,SRA,Library strategy,Genome_build,Supplementary_files_format_and_content
GSE84515,T47D DMSO 1,GSM2241147,Public on Mar 01 2017,Jul 18 2016,May 15 2019,SRA,1,Breast Cancer Cell,Homo sapiens,9606,"50,000 T47D cells were treated with DMSO or BYL719 1μM for 24hr.","T47D cells were maintained in RPMI 1640 with 10% FBS, 1% L-glutamine and 1% penicillin-streptomycin.",genomic DNA,"50,000 T47D cells were dissociated with acutase treatment and lysed with double the concentration of IGEPAL (0.2%) for successful library preparation., ATAC-seq libraries were prepared using Illumina's TruSeq ChIP sample prep.Libraries were validated using the Agient Technologies 2100 Bioanalyzer and Qubit high sensitivity assay.","Starting from fastq files containing ATAC-seq paired-end reads, sequencing adaptors were removed using Trimmomatic., Trimmed reads were mapped to the hg19 human genome using Bowtie2 allowing at most 1 seed mismatch and keeping only uniquely aligned reads., Duplicates were removed using Picard., For peak-calling the read start sites were adjusted (reads aligning to the +/- strand were offset by +4bp/-5bp, respectively) to represent the center of the transposon binding-event., Peak calling was performed on each condition individually by pooling reads from biological replicates, and using MACS2 with a permissive P-value threshold (-p 1e-2).",GPL11154,"Hatice,Ulku,Osmanbeyoglu",University of Pittsburgh,5117 Centre Ave,Pittsburgh,PA,15213,USA,Illumina HiSeq 2000,other,genomic,OTHER,"GSE84515, GSE84594",0,GSM2241147_T47D-DMSO-1-AT-A11.rmdup.rmChrM.Norm.bw,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2241nnn/GSM2241147/suppl/GSM2241147_T47D-DMSO-1-AT-A11.rmdup.rmChrM.Norm.bw,T47D DMSO 1,236897097,BW,breast,T47D,5 to 10,https://www.ncbi.nlm.nih.gov/biosample/SAMN05413979,https://www.ncbi.nlm.nih.gov/sra?term,ATAC-seq,hg19,bw files were generated using deeptools.
GSE84515,T47D DMSO 2,GSM2241148,Public on Mar 01 2017,Jul 18 2016,May 15 2019,SRA,1,Breast Cancer Cell,Homo sapiens,9606,"50,000 T47D cells were treated with DMSO or BYL719 1μM for 24hr.","T47D cells were maintained in RPMI 1640 with 10% FBS, 1% L-glutamine and 1% penicillin-streptomycin.",genomic DNA,"50,000 T47D cells were dissociated with acutase treatment and lysed with double the concentration of IGEPAL (0.2%) for successful library preparation., ATAC-seq libraries were prepared using Illumina's TruSeq ChIP sample prep.Libraries were validated using the Agient Technologies 2100 Bioanalyzer and Qubit high sensitivity assay.","Starting from fastq files containing ATAC-seq paired-end reads, sequencing adaptors were removed using Trimmomatic., Trimmed reads were mapped to the hg19 human genome using Bowtie2 allowing at most 1 seed mismatch and keeping only uniquely aligned reads., Duplicates were removed using Picard., For peak-calling the read start sites were adjusted (reads aligning to the +/- strand were offset by +4bp/-5bp, respectively) to represent the center of the transposon binding-event., Peak calling was performed on each condition individually by pooling reads from biological replicates, and using MACS2 with a permissive P-value threshold (-p 1e-2).",GPL11154,"Hatice,Ulku,Osmanbeyoglu",University of Pittsburgh,5117 Centre Ave,Pittsburgh,PA,15213,USA,Illumina HiSeq 2000,other,genomic,OTHER,"GSE84515, GSE84594",0,GSM2241148_T47D-DMSO-2-AT-A11.rmdup.rmChrM.Norm.bw,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2241nnn/GSM2241148/suppl/GSM2241148_T47D-DMSO-2-AT-A11.rmdup.rmChrM.Norm.bw,T47D DMSO 2,332595056,BW,breast,T47D,5 to 10,https://www.ncbi.nlm.nih.gov/biosample/SAMN05413980,https://www.ncbi.nlm.nih.gov/sra?term,ATAC-seq,hg19,bw files were generated using deeptools.
GSE84515,T47D BYL719 1,GSM2241149,Public on Mar 01 2017,Jul 18 2016,May 15 2019,SRA,1,Breast Cancer Cell,Homo sapiens,9606,"50,000 T47D cells were treated with DMSO or BYL719 1μM for 24hr.","T47D cells were maintained in RPMI 1640 with 10% FBS, 1% L-glutamine and 1% penicillin-streptomycin.",genomic DNA,"50,000 T47D cells were dissociated with acutase treatment and lysed with double the concentration of IGEPAL (0.2%) for successful library preparation., ATAC-seq libraries were prepared using Illumina's TruSeq ChIP sample prep.Libraries were validated using the Agient Technologies 2100 Bioanalyzer and Qubit high sensitivity assay.","Starting from fastq files containing ATAC-seq paired-end reads, sequencing adaptors were removed using Trimmomatic., Trimmed reads were mapped to the hg19 human genome using Bowtie2 allowing at most 1 seed mismatch and keeping only uniquely aligned reads., Duplicates were removed using Picard., For peak-calling the read start sites were adjusted (reads aligning to the +/- strand were offset by +4bp/-5bp, respectively) to represent the center of the transposon binding-event., Peak calling was performed on each condition individually by pooling reads from biological replicates, and using MACS2 with a permissive P-value threshold (-p 1e-2).",GPL11154,"Hatice,Ulku,Osmanbeyoglu",University of Pittsburgh,5117 Centre Ave,Pittsburgh,PA,15213,USA,Illumina HiSeq 2000,other,genomic,OTHER,"GSE84515, GSE84594",0,GSM2241149_T47D-BYL-1-AT-A11.rmdup.rmChrM.Norm.bw,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2241nnn/GSM2241149/suppl/GSM2241149_T47D-BYL-1-AT-A11.rmdup.rmChrM.Norm.bw,T47D BYL719 1,141126417,BW,breast,T47D,5 to 10,https://www.ncbi.nlm.nih.gov/biosample/SAMN05413981,https://www.ncbi.nlm.nih.gov/sra?term,ATAC-seq,hg19,bw files were generated using deeptools.
GSE84515,T47D BYL719 2,GSM2241150,Public on Mar 01 2017,Jul 18 2016,May 15 2019,SRA,1,Breast Cancer Cell,Homo sapiens,9606,"50,000 T47D cells were treated with DMSO or BYL719 1μM for 24hr.","T47D cells were maintained in RPMI 1640 with 10% FBS, 1% L-glutamine and 1% penicillin-streptomycin.",genomic DNA,"50,000 T47D cells were dissociated with acutase treatment and lysed with double the concentration of IGEPAL (0.2%) for successful library preparation., ATAC-seq libraries were prepared using Illumina's TruSeq ChIP sample prep.Libraries were validated using the Agient Technologies 2100 Bioanalyzer and Qubit high sensitivity assay.","Starting from fastq files containing ATAC-seq paired-end reads, sequencing adaptors were removed using Trimmomatic., Trimmed reads were mapped to the hg19 human genome using Bowtie2 allowing at most 1 seed mismatch and keeping only uniquely aligned reads., Duplicates were removed using Picard., For peak-calling the read start sites were adjusted (reads aligning to the +/- strand were offset by +4bp/-5bp, respectively) to represent the center of the transposon binding-event., Peak calling was performed on each condition individually by pooling reads from biological replicates, and using MACS2 with a permissive P-value threshold (-p 1e-2).",GPL11154,"Hatice,Ulku,Osmanbeyoglu",University of Pittsburgh,5117 Centre Ave,Pittsburgh,PA,15213,USA,Illumina HiSeq 2000,other,genomic,OTHER,"GSE84515, GSE84594",0,GSM2241150_T47D-BYL-2-AT-A11.rmdup.rmChrM.Norm.bw,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2241nnn/GSM2241150/suppl/GSM2241150_T47D-BYL-2-AT-A11.rmdup.rmChrM.Norm.bw,T47D BYL719 2,100112298,BW,breast,T47D,5 to 10,https://www.ncbi.nlm.nih.gov/biosample/SAMN05413982,https://www.ncbi.nlm.nih.gov/sra?term,ATAC-seq,hg19,bw files were generated using deeptools.
